首页> 外文期刊>The Journal of Urology >Classification of renal neoplasms based on molecular signatures.
【24h】

Classification of renal neoplasms based on molecular signatures.

机译:根据分子特征对肾肿瘤进行分类。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: Gene expression microarray studies have demonstrated distinct molecular signatures for different types of renal neoplasms based on overall gene expression patterns. However, in most of these studies the investigators used renal tumors with defined histology. We analyzed a test set of renal tumors in double-blind fashion using recently established molecular profiles of renal tumors as benchmarks. MATERIALS AND METHODS: A total of 16 consecutive nephrectomies performed for neoplasms at a single urological service were subjected to gene expression profiling using cDNA chips containing 21,632 genes. Analysis was clustered with our previously established molecular profiles of 91 histologically defined kidney neoplasms and comparative genomic microarray analysis while blinded to tumor histology and clinical information. RESULTS: With molecular analysis 9, 4, 2 and 1 tumors were classified as clear cell, papillary RCC, chromophobe RCC, and renal oncocytoma, respectively. Histopathological evaluation was concordant in 14 tumors. One of the 2 tumors with a discrepancy between molecular and pathological diagnoses was composed of oncocytoma and high grade clear cell RCC, and the other was chromophobe RCC that histologically mimicked papillary RCC. CONCLUSIONS: We report the feasibility of the molecular diagnosis and classification of unknown renal neoplasms. Molecular diagnosis appears to be reliable and comparable to the standard of urological pathology. This molecular method may be a potentially useful test for establishing an accurate diagnosis that can impact clinical management.
机译:目的:基因表达微阵列研究已经证明了基于整体基因表达模式的不同类型肾脏肿瘤的独特分子特征。然而,在大多数这些研究中,研究人员使用了组织学明确的肾肿瘤。我们以最近建立的肾脏肿瘤分子谱为基准,以双盲方式分析了一套肾脏肿瘤测试集。材料与方法:使用包含21,632个基因的cDNA芯片,对在一次泌尿科进行的总共16个连续的肾切除术进行了基因表达谱分析。分析与我们先前建立的91种组织学定义的肾脏肿瘤的分子概况和比较基因组微阵列分析相结合,而对肿瘤组织学和临床信息不了解。结果:通过分子分析,分别将9、4、2和1个肿瘤分为透明细胞癌,乳头状RCC,发色团RCC和肾上皮细胞瘤。在14个肿瘤中组织病理学评估一致。在分子和病理学诊断之间存在差异的2种肿瘤中,一种是由瘤细胞瘤和高级透明细胞RCC组成,另一种是在组织学上模仿乳头状RCC的生色团RCC。结论:我们报告了未知肾脏肿瘤的分子诊断和分类的可行性。分子诊断似乎是可靠的,可与泌尿外科病理学标准相媲美。该分子方法可能是用于建立可能影响临床管理的准确诊断的潜在有用测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号